Management of Cytokine Release Syndrome Associated with Chemotherapy Agents

New Orleans, LA US
June 16, 2022

The purpose of this activity is to provide pharmacy technicians and pharmacist with the latest updates in literature regarding newly approved therapies that may cause CRS and the treatment of CRS. The updates in the literature began with recent data published about the management of immunotherapy related toxicities and medication specific trials for new indications. Therapeutic treatment with immunotherapies such as CAR T-cell therapy and BiTE therapy can lead to life threatening or fatal CRS events. Through an extensive literature review, this presentation will summarize the important updates in management of CRS treatment to help pharmacist and pharmacy technicians understand the current therapies.

Target Audience

This activity is intended for Pharmacists and Pharmacy technicians.

Learning Objectives

At the completion of this activity Pharmacist will be able to:

  • Define cytokine release syndrome (CRS) and review its underlying pathophysiology
  • Analyze the mechanism of action of medications that are commonly associated with CRS
  • Describe the current approach to the treatment of CRS

At the completion of this activity Pharmacy technicians will be able to:

  • Discuss the symptoms commonly associated with CRS
  • Identify brand and generic names of the pharmacological agents that are commonly associated with CRS
  • Recognize brand and generic names of the pharmacological agents used in treatment of CRS


Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
Course opens: 
Course expires: 
Event starts: 
06/16/2022 - 1:00pm CDT
Event ends: 
06/16/2022 - 2:00pm CDT
Ochsner Medical Center
1514 Jefferson Hwy.
New Orleans, LA 70121
United States

Absence of Relevant Financial Relationships

None of the planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Randall Odom, PharmD
PGY1 Pharmacy Resident
Ochsner Medical Center
Planning committee members
Jessica Foy, PharmD, BCPS, BCOP
Clinical Pharmacy Specialist – BMT/Hematology Oncology
Ochsner Medical Center
Marissa Janusek, PharmD, BCPS, BCTXP
Clinical Pharmacy Specialist – Abdominal Transplant
Ochsner Medical Center
Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and Ochsner Medical Center. Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Designation Statement:
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-22-018-L01-P
Universal Activity Number: JA0006103-9999-22-018-L01-T

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
Please login or register to take this course.